STM Journals Peer-reviewed research from Consortium e-Learning Network

Research & Reviews: A Journal of Drug Design & Discovery Review Article

A Review on Nanosponges Drug Delivery System

  1. Rohit S. Marathe Department of Pharmaceutics, P.S.G.V.P., Mandal’s College of Pharmacy, Shahada
  2. Yogesh B. Rokote Department of Pharmaceutics, P.S.G.V.P., Mandal’s College of Pharmacy, Shahada

Abstract

The main issue that the researchers are dealing with is targeted medication delivery to locations. Crosslinking polymers produce nanosponges, which are three-dimensional drug delivery systems at the nanoscale. They have the benefit of having a large capacity to carry different-sized medications. There are numerous sizes and shapes for nanosponges. Compared to alternative delivery methods, nanosponges are preferable because they may offer a regulated medication release pattern with targeted Medication administration. Both the duration of the drug’s effect and its residence time may be controlled. The size of the drug molecule and the volume of empty space that is available dictate how well a drug is encapsulated. Applications for nanosponges include cancer treatment, oxygen delivery, enzyme and biocatalyst transporter solubility improvement, enzyme immobilization, and toxin absorbent. The process by which production, description, elements influencing the formation of nanosponges, drug loading and release mechanism, and the latest. This study highlights advancements made in this field and patents filed pertaining to nanosponges.

Keywords

References (45)

  1. Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R. Ultrasound-assisted synthesis of cyclodextrin-based nanosponges. EP 1 786 841 B1. United States patent application US 11/630,403. 2008 Sep 4.
  2. David F. Nanosponge drug delivery system more effective than direct injection. Pharm Dev Technol. 2011;16(4):367–376.
  3. Trotta F, Tumiatti V, Cavalli R, Rogero C, Mognetti B, Berta G. Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs. WO 2009/003656 A1. 2009.
  4. Aritomi H, Yamasaki Y, Yamada K, Honda H, Khoshi M. Development of sustained release formulation of chlorpheniramine maleate using powder coated microsponges prepared by dry impact blending method. J Pharm Sci Technol. 1996;56(1):49–56.
  5. Yurtdaş G, Demirel M, Genç L. Inclusion complexes of fluconazole with β-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2010;70(3-4):429-435. doi:10.1007/s10847-010-9908-z
  6. Zuruzi AS, MacDonald NC, Moskovits M, Kolmakov A. Metal Oxide “Nanosponges” as Chemical Sensors: Highly Sensitive Detection of Hydrogen with Nanosponge Titania. Angewandte Chemie International Edition. 2007;46(23):4298-4301. doi:10.1002/anie.200700006
  7. Selvamuthukumar S. Nanosponges: A novel class of drug delivery system—review. J Pharm Pharm Sci. 2012;15(1):103–11.
  8. Ambel V, Shailendra S, Swarnalatha S. J Incl Phenom Macrocycl Chem. 2008;62:23–42.
  9. S S, S A, Krishnamoorthy K, Rajappan M. Nanosponges: A Novel Class of Drug Delivery System - Review. Journal of Pharmacy & Pharmaceutical Sciences. 2012;15(1):103. doi:10.18433/j3k308
  10. Naga SJ, Nissankararao S, Bhimavarapu R, Sravanthi SL, Vinusha K. Nanosponges: A versatile drug delivery system. Int J Pharm Life Sci. 2013;4(8).
  11. Sharma R, Roderick B, Pathak K. Evaluation of kinetics and mechanism of drug release from econazole nitrate nanosponges loaded carbopol hydrogel. Indian J Pharm Educ Res. 2011;55(1):25–31.
  12. Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm. 2011;2(5):1520–1526.
  13. Guo L, Gao G, Liu X, Liu F. Preparation and characterization of TiO₂ nanosponge. Mater Chem Phys. 2008;111(2):322–325. doi:10.1186/1556-276X-6-551.
  14. Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm. 2011;2(5):1520–6.
  15. Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R. Ultrasound-assisted synthesis of cyclodextrin-based nanosponges. EP 1786841 B1. 2007 Jun 22.
  16. Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, et al. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. European Journal of Pharmaceutics and Biopharmaceutics. 2010;74(2):193-201. doi:10.1016/j.ejpb.2009.11.003
  17. S S, S A, Krishnamoorthy K, Rajappan M. Nanosponges: A Novel Class of Drug Delivery System - Review. Journal of Pharmacy & Pharmaceutical Sciences. 2012;15(1):103. doi:10.18433/j3k308
  18. Boscolo B, Trotta F, Ghibaudi E. High catalytic performances of Pseudomonas fluorescens lipase adsorbed on a new type of cyclodextrin-based nanosponges. Journal of Molecular Catalysis B: Enzymatic. 2010;62(2):155-161. doi:10.1016/j.molcatb.2009.10.002
  19. Cavalli R, Rogero CM, Mognetti B, Berta GN, Tumiatti V, Trotta F. Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs. WO 2009/003656 A1. 2009.
  20. Moura FCC, Lago RM. Catalytic growth of carbon nanotubes and nanofibers on vermiculite to produce floatable hydrophobic “nanosponges” for oil spill remediation. Applied Catalysis B: Environmental. 2009;90(3-4):436-440. doi:10.1016/j.apcatb.2009.04.003
  21. Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. International Journal of Pharmaceutics. 2010;402(1-2):254-257. doi:10.1016/j.ijpharm.2010.09.025
  22. Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes—A review. J Pharm Sci Technol. 2010;2:171–183.
  23. Ramnik S, Nitin B, Jyotsana M, Horemat SN. Characterization of cyclodextrin inclusion complexes—A review. J Pharm Sci Technol. 2010;2(3):171–183.
  24. Sharma R, Pathak K. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharmaceutical Development and Technology. 2010;16(4):367-376. doi:10.3109/10837451003739289
  25. Guo J, Xiao Y, Lin Y, Crommen J, Jiang Z. Effect of the crosslinker type on the enantioseparation performance of β -cyclodextrin functionalized monoliths prepared by the one-pot approach. Journal of Chromatography A. 2016;1467:288-296. doi:10.1016/j.chroma.2016.05.078
  26. Girek T, Ciesielski W. Polymerization of β-cyclodextrin with maleic anhydride along with thermogravimetric study of polymers. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2010;69(3-4):445-451. doi:10.1007/s10847-010-9778-4
  27. Tayade P, Modi A. A comparative solubility enhancement profile of valdecoxib with different solubilization approaches. Indian Journal of Pharmaceutical Sciences. 2007;69(2):274. doi:10.4103/0250-474x.33156
  28. Layre AM, Gref R, Richard J, Requier D, Chacun H, Appel M, et al. Nanoencapsulation of a crystalline drug. International Journal of Pharmaceutics. 2005;298(2):323-327. doi:10.1016/j.ijpharm.2005.02.039
  29. Ahire PS, Bhambere DS, Patil MP, Kshirsagar SJ. Recent advances in nanosponges as a drug delivery system. Indian J Drugs. 2020;8(1):8–17.
  30. Vyas A, Saraf S, Saraf S. Cyclodextrin based novel drug delivery systems. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2008;62(1-2):23-42. doi:10.1007/s10847-008-9456-y
  31. Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharmaceutica. 2013;63(3):335-358. doi:10.2478/acph-2013-0021
  32. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech. 2005;6(2):E329-E357. doi:10.1208/pt060243
  33. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech. 2005;6(2):E329–E357.
  34. Patel SB, Patel HJ, Seth AK. Nanosponge drug delivery system: An overview. J Glob Pharma Technol. 2010;2(8):1–9.
  35. Nacht S, Kantz M. The microsponge: A novel topical programmable delivery system. In: Topical Drug Delivery Systems. In: David WO, Anfon HA, editors. New York: Marcel Dekker; 1992. pp. 299–325.
  36. Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. International Journal of Pharmaceutics. 2010;402(1-2):254-257. doi:10.1016/j.ijpharm.2010.09.025
  37. Alongi J, Pošković M, Frache A, Trotta F. Novel flame retardants containing cyclodextrin nanosponges and phosphorus compounds to enhance EVA combustion properties. Polymer Degradation and Stability. 2010;95(10):2093-2100. doi:10.1016/j.polymdegradstab.2010.06.030
  38. Arnum PV. Nanosponges, a controlled-release nanoparticle system, shows promise in targeted drug delivery. Pharm Technol. 2011;35:56–60.
  39. Alongi J, Poskovic M, Frache A, Trotta F. Role of β-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydrate Polymers. 2011;86(1):127-135. doi:10.1016/j.carbpol.2011.04.022
  40. Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study. AAPS PharmSciTech. 2011;12(1):279-286. doi:10.1208/s12249-011-9584-3
  41. Trotta F, Cavalli R, Martina K, Biasizzo M, Vitillo J, Bordiga S, et al. Cyclodextrin nanosponges as effective gas carriers. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2011;71(1-2):189-194. doi:10.1007/s10847-011-9926-5
  42. Cavalli R, Ansari KA, Bisazza A, Giustetto P, Trotta F. Cyclodextrin-based nanosponges for pharmaceutical applications. J Incl Phenom Macrocycl Chem. 2022. doi:10.1007/s10847-011-9926-5.
  43. Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study. AAPS PharmSciTech. 2011;12(1):279-286. doi:10.1208/s12249-011-9584-3
  44. Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm. 2011;2(5):1520–1526.
  45. Amber V, Shailendra S, Swarnalatha S. Cyclodextrin based novel drug delivery systems. J Pharm Sci. 2012;62:23–42.
Support